Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services (Systems & Software, Consumables, Service), By Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Others), By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others), By Company, and By Region

November 2022 | 117 pages | ID: G3BC9C26B38DEN
TechSci Research

Abstracts

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing specialized medicines and wide application of genomics in numerous areas. Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes. Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes. Nowadays, people are diagnosed with genetic as well as chronic diseases due to which demand for personalized medicine is surging, which is bolstering the growth of the market. The other factors supporting the market's growth are, advancement in diagnostic techniques, increasing investments by governments, surge in cancer incidents and rise in R&D initiatives.

Increasing Demand of Specialized/Personalized Medicine

Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market. The ability to advance health care facilities by providing unique clinical, genetic, genomic, and environmental information is increasing the importance of genomics. Surging demand of Personalized medicines is due to their efficiency to treat unique, yet complex diseases. They help medical researchers to identify the exact requirement of patient and then treat them accordingly. Based on the 2020 Scope and Significance of Progress report, personalized medicines accounted for around 39 percent of the total FDA-approved new drugs in the year. Doctors, researchers, and pharmaceutical firms are using precision medicine for developing new drug and disease therapies, and unique clinical testing. Personalized medicine uses all genes in human genome for identification, prevention, and treatment of any complex disease.

Growing Application of Genomics in Various Sectors.

The use of genomics concepts in the field of synthetic biology, healthcare, study gene sequences of plants and organisms, and bioengineering sectors are some of the applications, which is anticipating the growth of the market. For instance, agricultural genomics is a field that is contributing to advances in crop development such as it can lessen the trials and failures involved in scientific research to a certain extent, which could enhance the quality and quantity of crop yields in agriculture. In December 2020, Calyxt, Inc. announced signing a research collaboration with NRGene Ltd. that comprises the use of the cloud-based genomic platform of NRGene to fast-track hemp trait discovery.

Technological Advancements

Rapid advancements and innovations in the genomics sector are bolstering the growth of the market. The advent of cheaper nucleic acid sequencing is modifying DNA and RNA on demand. Sensing the increasing demand several companies are offering sequencing services for nutrition, ancestry, and genetic diseases. Rapid advances in microscopy are also in process. For instance, in 2019, Thermo Fisher Scientific, Inc. (US) introduced the Oncomine Precision Assay, an innovative pan-cancer panel, for its Genexus platform to advance precision medicine in clinical settings. Other factors, such as massive research and development (R&D) activities in the bioinformatics sector and the increasing demand for next-generation sequencing services, are anticipating the growth of the market.

Market Segmentation

The global genomics market is segmented into products & services, technology, application, end user, and company. Based on products & services, the market is divided into systems & software, consumables, and service. Based on technology, the market is divided into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on application, the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. Based on end user, the market is divided into hospitals & clinics, academic & research institutions, biotechnology & pharmaceutical companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising importance of personalized medicines and wide application of genomics in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global genomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Genomics Market, By Products & Services:
• Systems & Software
• Consumables
• Service
• Genomics Market, By Technology:
• Sequencing
• PCR
• Nucleic Acid Extraction and Purification
• Microarray
• Others
• Genomics Market, By Application:
• Drug Discovery & Development
• Diagnostics
• Agriculture & Animal Research
• Others
• Genomics Market, By Application:
• Hospitals & Clinics
• Academic & Research Institutions
• Biotechnology & Pharmaceutical Companies
• Others
• Genomics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Europe & CIS
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Genomics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL GENOMICS MARKET

4. VOICE OF CUSTOMER

5. EXECUTIVE SUMMARY

6. GLOBAL GENOMICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Products & Services (Systems & Software, Consumables, Service)
  6.2.2. By Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Others)
  6.2.3. By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Others)
  6.2.4. By End User (Hospitals & Clinics, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
  6.2.5. By Company (2021)
  6.2.6. By Region
6.3. Market Map

7. NORTH AMERICA GENOMICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Products & Services
  7.2.2. By Technology
  7.2.3. By Application
  7.2.4. By End User
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Genomics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product & Services
      7.3.1.2.2. By Technology
      7.3.1.2.3. By Application
      7.3.1.2.4. By End User
  7.3.2. Mexico Genomics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product & Services
      7.3.2.2.2. By Technology
      7.3.2.2.3. By Application
      7.3.2.2.4. By End User
  7.3.3. Canada Genomics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product & Services
      7.3.3.2.2. By Technology
      7.3.3.2.3. By Application
      7.3.3.2.4. By End User

8. EUROPE GENOMICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Products & Services
  8.2.2. By Technology
  8.2.3. By Application
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France Genomics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product & Services
      8.3.1.2.2. By Technology
      8.3.1.2.3. By Application
      8.3.1.2.4. By End User
  8.3.2. Germany Genomics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product & Services
      8.3.2.2.2. By Technology
      8.3.2.2.3. By Application
      8.3.2.2.4. By End User
  8.3.3. United Kingdom Genomics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product & Services
      8.3.3.2.2. By Technology
      8.3.3.2.3. By Application
      8.3.3.2.4. By End User
  8.3.4. Italy Genomics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product & Services
      8.3.4.2.2. By Technology
      8.3.4.2.3. By Application
      8.3.4.2.4. By End User
  8.3.5. Spain Genomics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product & Services
      8.3.5.2.2. By Technology
      8.3.5.2.3. By Application
      8.3.5.2.4. By End User

9. ASIA-PACIFIC GENOMICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Products & Services
  9.2.2. By Technology
  9.2.3. By Application
  9.2.4. By End User
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Genomics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product & Services
      9.3.1.2.2. By Technology
      9.3.1.2.3. By Application
      9.3.1.2.4. By End User
  9.3.2. India Genomics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product & Services
      9.3.2.2.2. By Technology
      9.3.2.2.3. By Application
      9.3.2.2.4. By End User
  9.3.3. Japan Genomics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product & Services
      9.3.3.2.2. By Technology
      9.3.3.2.3. By Application
      9.3.3.2.4. By End User
  9.3.4. South Korea Genomics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Product & Services
      9.3.4.2.2. By Technology
      9.3.4.2.3. By Application
      9.3.4.2.4. By End User
  9.3.5. Australia Genomics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Product & Services
      9.3.5.2.2. By Technology
      9.3.5.2.3. By Application
      9.3.5.2.4. By End User

10. SOUTH AMERICA GENOMICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Products & Services
  10.2.2. By Technology
  10.2.3. By Application
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Genomics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product & Services
      10.3.1.2.2. By Technology
      10.3.1.2.3. By Application
      10.3.1.2.4. By End User
  10.3.2. Argentina Genomics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product & Services
      10.3.2.2.2. By Technology
      10.3.2.2.3. By Application
      10.3.2.2.4. By End User
  10.3.3. Colombia Genomics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product & Services
      10.3.3.2.2. By Technology
      10.3.3.2.3. By Application
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA GENOMICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Products & Services
  11.2.2. By Technology
  11.2.3. By Application
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Genomics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Product & Services
      11.3.1.2.2. By Technology
      11.3.1.2.3. By Application
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia Genomics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Product & Services
      11.3.2.2.2. By Technology
      11.3.2.2.3. By Application
      11.3.2.2.4. By End User
  11.3.3. UAE Genomics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Product & Services
      11.3.3.2.2. By Technology
      11.3.3.2.3. By Application
      11.3.3.2.4. By End User
  11.3.4. Egypt Genomics Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Product & Services
      11.3.4.2.2. By Technology
      11.3.4.2.3. By Application
      11.3.4.2.4. By End User
  11.3.5. Turkey Genomics Market Outlook
    11.3.5.1. Market Size & Forecast
      11.3.5.1.1. By Value
    11.3.5.2. Market Share & Forecast
      11.3.5.2.1. By Product & Services
      11.3.5.2.2. By Technology
      11.3.5.2.3. By Application
      11.3.5.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Illumina, Inc.
14.2. Thermo Fischer Scientific, Inc.
14.3. QIAGEN N.V.
14.4. Agilent Technologies, Inc.
14.5. F. Hoffmann-La Roche AG
14.6. Bio-Rad Laboratories, Inc.
14.7. Eurofins Scientific SE
14.8. Oxford Nanopore Technologies Limited
14.9. Pacific Biosciences of California, Inc.
14.10. Danaher Corporation
14.11. GE Healthcare
14.12. Myriad Genetics, Inc.
14.13. 23andMe, Inc.
14.14. Eppendorf AG
14.15. Quest Diagnostics Inc.

15. STRATEGIC RECOMMENDATIONS